Additionally, PD-L1 can also be detected in the bloodstream as a soluble molecule (sPD-L1), with higher concentrations observed in patients with NSCLC compared to healthy donors (HD) [20]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.